Interactive Simulation to Train Prescription Drug Abuse Screening

描述（由申请人提供）：由于几个原因，处方药滥用日益受到关注。获得多种处方和早期补充的便利给使用处方药的患者带来了许多健康风险。由于多次处方或早期补药没有得到密切监测，因此有时由初级保健医生来适当筛查潜在的处方药滥用和成瘾迹象。初级保健机构的临床医生应具备识别潜在滥用迹象的知识，并采取必要步骤处理被认为对处方药成瘾或滥用处方药的患者。这种相互作用可能是困难的，因为许多患者要么不知道，要么回避他们的成瘾或滥用。提供模拟培训，帮助临床医生更好地筛选潜在的处方药滥用患者，将是非常有效的。在第一阶段的应用中，SIMmersion LLC与威斯康辛大学的Michael Fleming博士合作，建议开发一个交互式模拟原型，用于培训初级保健机构的临床医生的处方药滥用筛查技能。拟议的培训模拟将允许医生和其他初级保健从业人员练习筛选、干预和转诊技能，与虚拟患者识别潜在的处方药滥用，并在必要时提供适当的干预。理想的结果是临床医生对这些技能变得更加熟练和舒适，因此更有可能将它们作为所有患者的常规实践的一部分，从而通过早期识别和干预将处方药滥用的影响降至最低。由临床医生组成的专家小组将协助开发和审查原型模拟。一旦完成，该小组将对各种措施的模拟进行评估，以确定其在实地使用的可行性。如果在第一阶段成功建立了处方药滥用筛查的可行性，该原型将在第二阶段扩展，包括对处方药滥用筛查阳性或显示与潜在处方药滥用和/或滥用相关的风险迹象的患者进行简短干预。该模拟有望成为寻求获得处方药滥用筛选和简短干预技能的新临床医生和寻求更新或改进现有技能的经验丰富的临床医生的有用工具。公共卫生相关性：帮助初级保健临床医生获得筛查患者处方药物滥用能力的创新和经济技术有助于提高筛查潜在滥用的频率和效力。在初级保健机构对患者进行处方药滥用筛查可能有助于更快地发现滥用情况，并导致改变生活的干预措施，从而减少处方药和其他药物滥用和成瘾的负面影响。

DESCRIPTION (provided by applicant): Prescription drug abuse is a growing concern for several reasons. The facility of attaining multiple prescriptions and getting early refills poses a number of health risks for patients who use prescription drugs. Since multiple prescriptions or early refills are not closely monitored, it is sometimes up to the primary care physician to properly screen for signs of potential prescription drug abuse and addiction. Clinicians in primary care settings should be equipped with the knowledge to recognize the signs of potential abuse, as well as the steps necessary to address patients who are deemed to be addicted to or abusing prescription drugs. The interaction can be difficult, since many patients are either unaware or evasive about their addiction or abuse. Providing simulation training to help prepare clinicians to better screen patients for potential prescription drug abuse would be very effective. For the Phase I application, SIMmersion LLC, in cooperation with Dr. Michael Fleming of the University of Wisconsin, proposes to develop a prototype interactive simulation to train prescription drug abuse screening skills for clinicians in primary care settings. The proposed training simulation will allow physicians and other primary healthcare practitioners to practice screening, intervention, and referral skills with a virtual patient to identify potential prescription drug abuse and provide appropriate intervention when necessary. The ideal outcome would for be for clinicians to become more proficient and comfortable with these skills and therefore more likely to use them as a routine part of their practice with all patients, thereby minimizing the effects of prescription drug abuse through early identification and intervention. An expert panel composed of clinicians will assist in the development and review of the prototype simulation. Once completed, the panel will evaluate the simulation on a variety of measures to determine its feasibility for use in the field. If feasibility is successfully established during Phase I for prescription drug abuse screening, the prototype will be expanded in Phase II to include brief intervention for patients who screen positively for prescription drug abuse or show risk signs associated with potential prescription drug misuse and/or abuse. The simulation is expected to be a useful tool for new clinicians seeking to acquire prescription drug abuse screening and brief intervention skills and experienced clinicians seeking to refresh or refine existing skills. PUBLIC HEALTH RELEVANCE: Innovative and economical technologies that assist primary care clinicians in acquiring competence in screening patients for prescription drug abuse could help increase the frequency and efficacy of screening for potential abuse. Screening patients for prescription drug abuse in primary care settings may help identify abuse sooner and lead to life-changing interventions which could reduce the negative impact of prescription and other drug abuse and addiction.